These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9237094)

  • 1. New protein engineering approaches to multivalent and bispecific antibody fragments.
    Plückthun A; Pack P
    Immunotechnology; 1997 Jun; 3(2):83-105. PubMed ID: 9237094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
    Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
    Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
    Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
    J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and application of diabodies, triabodies and tetrabodies for cancer targeting.
    Todorovska A; Roovers RC; Dolezal O; Kortt AA; Hoogenboom HR; Hudson PJ
    J Immunol Methods; 2001 Feb; 248(1-2):47-66. PubMed ID: 11223068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments.
    Lu D; Jimenez X; Zhang H; Bohlen P; Witte L; Zhu Z
    J Immunol Methods; 2002 Sep; 267(2):213-26. PubMed ID: 12165442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes.
    Connelly RJ; Hayden MS; Scholler JK; Tsu TT; Dupont B; Ledbetter JA; Kanner SB
    Int Immunol; 1998 Dec; 10(12):1863-72. PubMed ID: 9885907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and expression of bi-functional proteins of single-chain Fv with effector domains.
    Luo D; Mah N; Wishart D; Zhang Y; Jacobs F; Martin L
    J Biochem; 1996 Aug; 120(2):229-32. PubMed ID: 8889803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules.
    Jordan JL; Arndt JW; Hanf K; Li G; Hall J; Demarest S; Huang F; Wu X; Miller B; Glaser S; Fernandez EJ; Wang D; Lugovskoy A
    Proteins; 2009 Dec; 77(4):832-41. PubMed ID: 19626705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for generating multivalent and bispecific antibody fragments.
    Tomlinson I; Holliger P
    Methods Enzymol; 2000; 326():461-79. PubMed ID: 11036658
    [No Abstract]   [Full Text] [Related]  

  • 12. Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidase.
    Atwell JL; Pearce LA; Lah M; Gruen LC; Kortt AA; Hudson PJ
    Mol Immunol; 1996 Dec; 33(17-18):1301-12. PubMed ID: 9171890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Diabodies": small bivalent and bispecific antibody fragments.
    Holliger P; Prospero T; Winter G
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design.
    Deyev SM; Lebedenko EN
    Bioessays; 2008 Sep; 30(9):904-18. PubMed ID: 18693269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dimeric bispecific miniantibody combines two specificities with avidity.
    Müller KM; Arndt KM; Plückthun A
    FEBS Lett; 1998 Jul; 432(1-2):45-9. PubMed ID: 9710248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
    Albrecht H; Denardo GL; Denardo SJ
    J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.
    Muda M; Gross AW; Dawson JP; He C; Kurosawa E; Schweickhardt R; Dugas M; Soloviev M; Bernhardt A; Fischer D; Wesolowski JS; Kelton C; Neuteboom B; Hock B
    Protein Eng Des Sel; 2011 May; 24(5):447-54. PubMed ID: 21498564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.
    Kipriyanov SM; Moldenhauer G; Schuhmacher J; Cochlovius B; Von der Lieth CW; Matys ER; Little M
    J Mol Biol; 1999 Oct; 293(1):41-56. PubMed ID: 10512714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapy.
    DeNardo DG; Xiong CY; Shi XB; DeNardo GL; DeNardo SJ
    Cancer Biother Radiopharm; 2001 Dec; 16(6):525-35. PubMed ID: 11789029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.